A pharmacist-led medicines review intervention in community-dwelling Māori older adults- a feasibility study protocol.

Show simple item record

dc.contributor.author Hikaka, Joanna
dc.contributor.author Hughes, Carmel
dc.contributor.author Jones, Rhys
dc.contributor.author Connolly, Martin J
dc.contributor.author Martini, Nataly
dc.coverage.spatial United States
dc.date.accessioned 2024-03-13T22:03:04Z
dc.date.available 2024-03-13T22:03:04Z
dc.date.issued 2020-09
dc.identifier.citation (2020). Research in Social and Administrative Pharmacy, 16(9), 1264-1271.
dc.identifier.issn 1551-7411
dc.identifier.uri https://hdl.handle.net/2292/67698
dc.description.abstract <h4>Background</h4>Pharmacists have a role to play in supporting the optimal use of medicines to ensure older adults receive therapeutic benefit whilst minimising medicines-related harm. In Aotearoa New Zealand (NZ), Māori (Indigenous people of NZ) experience inequities in the determinants of health, including access to medicines, resulting in increased morbidity, earlier onset of chronic conditions and reduced life expectancy. This study aims to test the feasibility of a pharmacist-led medicines review intervention in community-dwelling Māori older adults.<h4>Method</h4>This is a non-randomised, non-controlled feasibility study undertaken within a kaupapa Māori methodological framework which supports the right of Māori to be included throughout the research process and seeks to potentiate transformational, positive change for Māori. The research pharmacist will recruit 30 participants (Māori; 55 years or older; community-dwelling). Participants will undergo a medicines education session with the pharmacist (medicines reconciliation, medicines information, well-being goal setting), with the option to proceed to a medicines optimisation session that includes the participant, pharmacist and primary prescriber (review of potentially inappropriate prescribing (PIP); medicines management plan development). Primary outcomes: participant and prescriber acceptability of intervention. Secondary outcomes include baseline and post-intervention medicines knowledge, PIP and quality of life scores, and number of changes made to the medicines regimen.<h4>Ethics and dissemination</h4>Ethical approval was granted by the Northern B Health and Disability Committee (9/NTB/106). Study results will be disseminated to various stakeholders including Māori communities, health practitioners and providers, and researchers through meetings and conference presentations, lay summaries and peer-reviewed journals. This study is an example of health service design, delivery and evaluation, informed by Indigenous knowledge and methodology, developed explicitly to address inequities in health outcomes for, and with, Māori and will inform the decision to proceed to a randomised controlled trial to test the effect of this intervention.<h4>Trial registration number</h4>ACTRN12619001070123.
dc.format.medium Print-Electronic
dc.language eng
dc.publisher Elsevier
dc.relation.ispartofseries Research in social & administrative pharmacy : RSAP
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.subject Humans
dc.subject Feasibility Studies
dc.subject Quality of Life
dc.subject Aged
dc.subject Pharmacists
dc.subject New Zealand
dc.subject Randomized Controlled Trials as Topic
dc.subject Independent Living
dc.subject Health service development
dc.subject Indigenous health
dc.subject Medicines review
dc.subject Older adults
dc.subject Pharmaceutical services
dc.subject 4203 Health Services and Systems
dc.subject 42 Health Sciences
dc.subject Prevention
dc.subject Clinical Research
dc.subject Aging
dc.subject 8 Health and social care services research
dc.subject 8.1 Organisation and delivery of services
dc.subject Generic health relevance
dc.subject 3 Good Health and Well Being
dc.subject Science & Technology
dc.subject Life Sciences & Biomedicine
dc.subject Public, Environmental & Occupational Health
dc.subject Pharmacology & Pharmacy
dc.subject ADVERSE DRUG-REACTIONS
dc.subject NEW-ZEALAND
dc.subject HOSPITALIZATION
dc.subject MEDICATION
dc.subject MORTALITY
dc.subject CRITERIA
dc.subject ACCESS
dc.subject IMPACT
dc.subject 1117 Public Health and Health Services
dc.subject Health services & systems
dc.subject Public Health
dc.subject 1115 Pharmacology and Pharmaceutical Sciences
dc.subject 4206 Public health
dc.title A pharmacist-led medicines review intervention in community-dwelling Māori older adults- a feasibility study protocol.
dc.type Journal Article
dc.identifier.doi 10.1016/j.sapharm.2019.12.004
pubs.issue 9
pubs.begin-page 1264
pubs.volume 16
dc.date.updated 2024-02-23T00:25:18Z
dc.rights.holder Copyright: Elsevier Inc. en
dc.identifier.pmid 31813763 (pubmed)
pubs.author-url https://www.ncbi.nlm.nih.gov/pubmed/31813763
pubs.end-page 1271
pubs.publication-status Published
dc.rights.accessrights http://purl.org/eprint/accessRights/RetrictedAccess en
pubs.subtype Clinical Trial Protocol
pubs.subtype Controlled Clinical Trial
pubs.subtype Research Support, Non-U.S. Gov't
pubs.subtype Journal Article
pubs.elements-id 790157
pubs.org-id Medical and Health Sciences
pubs.org-id Te Kupenga Hauora Maori
pubs.org-id Pharmacy
pubs.org-id School of Medicine
pubs.org-id Medicine Department
dc.identifier.eissn 1934-8150
dc.identifier.pii S1551-7411(19)30741-7
pubs.record-created-at-source-date 2024-02-23
pubs.online-publication-date 2019-12-05


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics